Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment Shortage
Last Updated: March 30, 2022
Status: Current
Products Affected - Description
-
- Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Perrigo, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00574-4160-35
Reason for the Shortage
-
- Bausch Health has neomycin/polymyxin B sulfates/dexamethasone ophthalmic ointment available.
- Novartis has Maxitrol ointment available.
- Perrigo did not provide a reason for the shortage.
- Sandoz has neomycin/polymyxin B sulfates/dexamethasone ophthalmic ointment available.
Available Products
-
- Maxitrol ophthalmic ointment, Novartis, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00078-0771-01
- Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Bausch Health, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 24208-0795-35
- Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Sandoz, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 61314-0631-36
Estimated Resupply Dates
-
- Perrigo has temporarily discontinued neomycin/polymyxin B/dexamethasone ophthalmic ointment in 3.5 gram tubes and the company cannot estimate a release date. All other presentations are available.
Updated
Updated March 30, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 17, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.